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Rinderpest causes a devastating disease, often fatal, in wild and domestic ruminants. It has been eradicated successfully using a live,
attenuated vaccine from most part of the world leaving a few foci of disease in parts of Africa, the Middle East, and South Asia. We have
developed transgenic peanut (Arachis hypogaea L.) plants expressing hemagglutinin (H) protein of rinderpest virus (RPV), which is
antigenically authentic. In this work, we have evaluated the immunogenicity of peanut-expressed H protein using mouse model, administered
parenterally as well as orally. Intraperitoneal immunization of mice with the transgenic peanut extract elicited antibody response specific to
H. These antibodies neutralized virus infectivity in vitro. Oral immunization of mice with transgenic peanut induced H-specific serum IgG
and IgA antibodies. The systemic and oral immunogenicity of plant-derived H in absence of any adjuvant indicates the potential of edible
vaccine for rinderpest.
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Introduction potency of the vaccine. Several attempts have been made toRinderpest virus (RPV) is an important member of the
genus Morbillivirus in the family Paramyxoviridae. RPV
causes an acute, febrile, and highly contagious disease
characterized by high fever, erosive stomatitis, gastroenter-
itis, dehydration, and death (Scott, 1964). It affects primarily
cattle and buffaloes; although all the members of the order
Artiodactyla are susceptible to natural infection (Scott,
1959), the infection spreads rapidly through close contact
with infected animals. There is only one serotype of RPV,
which is highly immunogenic. A live, attenuated tissue
culture-adapted vaccine developed by Plowright (1962) is
very effective and is one of the few tools available to control
the spread of disease. However, because the vaccine is heat
labile, it requires maintenance of cold chain to keep the0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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apolis, USA.develop a heat stable vaccine, using vaccinia, capripox, and
baculoviruses as vectors (Bassiri et al., 1993; Naik et al.,
1997; Romero et al., 1993, 1994; Yilma et al., 1988). The
recombinant viral vectors were designed to express RPV
surface glycoproteins namely hemagglutinin (H) and fusion
(F) protein alone or in combination. The efficacy of these
recombinants as a vaccine has been tested in experimental
animals and shown to induce humoral and cell-mediated
protective immune response. Recombinant vaccinia ex-
pressing H has been shown to provide long-term immunity
in cattle (Ohishi et al., 2000; Verardi et al., 2002) and also
recombinant capripox rinderpest virus vaccine has recently
been tested for long-term immunity in African cattle (Ngi-
chabe et al., 2002). In spite of being robust, these subunit
vaccines are not cost effective if they are required for mass
vaccination purposes. Another point of consideration is that
all these attempts are oriented toward parenteral delivery of
the antigens. Because most of the pathogen colonize and
invade the host at mucosal surfaces, the induction of
immunity through vaccination at these sites is a logical
and attractive approach to prevent infection. Parenteral
A. Khandelwal et al. / Virology 323 (2004) 284–291 285antigen delivery does not induce significant mucosal immu-
nity, which is better achieved by delivery of the antigen
orally. Mucosal delivery could become a better tool for the
management of diseases associated with mucosal surface.
Use of plants as an expression system not only provides
an economical means of bulk production of foreign proteins
but also oral uptake of edible parts of the transgenic plants
expressing protective antigens that will induce the desired
mucosal immune response. The concept of edible vaccine
put forward by Arntzen (Mason et al., 1992) is followed by
development of transgenic plants expressing a variety of
antigens from disease-causing organisms especially of hu-
man interest (Haq et al., 1995; Huang et al., 2001; Mason et
al., 1996; McGarvey et al., 1995; Sandhu et al., 2000;
Thanavala et al., 1995). Human trials have shown the
induction of mucosal and systemic immune response to
antigen delivered in the form of uncooked food (Tacket et
al., 1998). In order to produce an edible vaccine for
rinderpest, it is necessary to look for the expression of the
protective antigen in a model plant system and test the
immunogenicity of the expressed protein. We have recently
developed transgenic tobacco expressing hemagglutinin
protein of RPV and shown that tobacco-derived H is able
to induce good levels of specific immune response in mouse
when inoculated intraperitoneally (Khandelwal et al.,
2003a). For oral delivery of a vaccine antigen, targeted crop
should produce the antigen in edible tissues that can be
eaten raw. Grains and legumes are the commonly used
fodder for animal consumption. Peanut (Arachis hypogaea
L.), an oil seed legume, is used as a fodder crop in many
tropical and subtropical regions of the world. We commu-
nicate in the present study the antigenic authenticity of
hemagglutinin protein of rinderpest virus expressed in
transgenic peanut (A. hypogaea L.) plants and its oral
immunogenicity. The immune response was evaluated in a
mouse model. Induction of high levels of specific antibody
response to peanut-derived H was observed upon intraper-
itoneal immunization. The protective ability of H-specific
antibodies was demonstrated by neutralization of virus
infectivity in vitro. Oral immunization of mice with trans-
genic peanut leaves expressing H elicited significant muco-
sal and systemic immune response. To our knowledge, this
is the first report demonstrating induction of mucosal
immune response to RPV antigen delivered orally. Thus,
transgenic peanut plants expressing H could provide a novel
way of mass immunization of cattle and susceptible wild
life.Results
Peanut-derived hemagglutinin protein is antigenically
authentic
The authenticity of peanut-derived hemagglutinin pro-
tein was determined by its reactivity with different anti-bodies specific to H in ELISA (Fig. 1). Protein extracts
were made from leaves of transgenic plants expressing H
from both T1 and T2 generations and also from vector-
transformed plant. The protein extract from transgenic
plants reacted with serum from cattle immunized with
baculo-recombinant H (Figs. 1B and C) and convalescent
serum from cattle recovered after RPV infection (Figs. 1D–
F). The peanut-derived H cross-reacted well with antibodies
to hemagglutinin neuraminidase protein (HN) of antigeni-
cally related virus, peste des petits ruminants virus (PPRV)
(Fig. 1G), and also with convalescent serum from sheep
infected with PPRV (Fig. 1H). The protein extract from
vector-transformed peanut plant did not show reactivity to
any of these antibodies. These results showed that H-
expressed in peanut plants is antigenically similar to vi-
rus-derived H protein.
Peanut-derived hemagglutinin induces specific antibody
response upon intraperitoneal immunization
BALB/c mice received transgenic peanut extract or vec-
tor-transformed peanut extract through intraperitoneal im-
munization. Serum samples were tested in ELISA for the
presence of specific antibodies using recombinant H as
antigen. High levels of specific antibody to H were detected
in the serum from mice immunized with transgenic peanut
extract (Fig. 2A). The serum from all the five animals of each
group (group 1: immunized with transgenic peanut extract,
and group 2: vector-transformed peanut extract) was tested
individually. The antibody response was monitored until 9
weeks post-immunization and the immunized animals main-
tained good levels of antibody. The specificity of these
antibodies was confirmed by their reactivity to H protein
made in infected cells by immunoblotting (Fig. 2B). A
protein band at approximately 68 kDa was detected only in
protein extracts from RPV-infected cells (lane 2), PPRV-
infected cells (lane 3), and no signals were detected with
uninfected Vero cell extract (lane 1) when pooled serum from
peanut-H immunized animals was used as primary antibody.
No detectable signals were obtained when serum from mice,
which received vector-transformed peanut extract, was used
as primary antibody (data not shown).
The specificity of the antibody produced following
intraperitoneal immunization with peanut-derived H was
further evaluated by hemagglutination inhibition assay.
The hemagglutinin protein of antigenically closely related
virus, peste des petits ruminants virus (PPRV), has been
shown to possess hemagglutination activity (Ramachandran
et al., 1995). Therefore, the inhibition of hemagglutination
activity of PPRV by pooled serum from all the five mice of
group 1 collected at weekly intervals was tested and shown
to possess hemagglutination inhibition activity (Fig. 3). This
hemagglutination inhibition activity was not observed when
pooled serum from all the five mice of group 2 was used in a
similar assay, thus showing the specificity of antibody
response.
Fig. 1. Antigenic authenticity of plant-derived H. Reactivity of extracts from transgenic peanut plants of two generations, T1 and T2, and vector-transformed
peanut extract with normal cattle sera (A), reactivity of the same extracts with sera from two different cattle (C1 and C2) immunized with recombinant H (B and
C). Panels D, E, and F show the reactivity of T1 and T2 peanut extracts and vector-transformed peanut extract to convalescent sera obtained from three different
buffaloes (#6, #63, #64), respectively. Panels G and H show cross-reactivity of T1 and T2 peanut-derived H and vector-transformed peanut, respectively, with
convalescent sera from sheep recovered from PPRV infection and with antibody to PPRV-HN. Circle (.), triangle (E), and square (n) represent T1 extract, T2
extract, and vector-transformed peanut extract, respectively.
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generates antibody, which neutralizes virus infectivity
in vitro
The protective ability of specific antibody elicited follow-
ing intraperitoneal immunization with extract from transgen-
ic peanut expressing Hwas demonstrated by neutralization of
virus infectivity in vitro. Table 1 shows the induction of high
titers of neutralizing antibodies. These immune sera are not
only able to neutralize RPV infectivity but also PPRV
infectivity in vitro (data not shown). However, no neutrali-
zation or cross-neutralization activity was detected when
pooled serum from mice of group 2 was tested in vitro.
Oral immunization with transgenic peanut leaves expressing
H induces mucosal and systemic immune response
Mice were fed with either 1 g transgenic peanut leaves
pooled from different lines expressing H (f0.5% of total
soluble protein) or with 1 g nontransformed peanut leaves.
The serum was collected every week and analyzed for thepresence of H specific IgG (Fig. 4A) and IgA (Fig. 4B). The
peanut-derived H was able to induce significant levels of
serum IgG in 1 week. The booster effect was not apparent
until fourth week at which time the level of antibody had
decreased compared to the first week. There was also an
increase in IgA level that followed a similar trend. The
reason for the initial surge in the antibody levels and a
delayed booster effect is not clear. H-specific serum IgG or
IgA level was maintained almost at the same levels, and the
given dose did not result in oral tolerance. The animals,
which received the antigen through oral route, showed the
presence of secretory antibody in the intestinal extract even
after 13 weeks post-immunization (data not shown). Mice
that received nontransformed peanut leaves did not elicit
any H-specific antibody response.
Oral delivery of peanut-derived H elicits
lymphoproliferative responses
The splenocytes collected from mice at 13 weeks post-
oral immunization with transgenic peanut leaves showed
Table 1
In vitro neutralization of RPV infectivity by serum collected from mice after
intraperitoneal immunization with transgenic leaf extract or with vector-
transformed peanut leaf extract
Virus neutralization
titer*
Days post-immunization
Antigen 0 7 14 21 28 35 42 49 56 63
Vector-transformed
peanut protein
0 0 0 0 0 0 0 0 0 0
Transgenic H
peanut protein
0 1280 1280 1280 1280 320 320 320 160 160
*Virus neutralization titre is defined as the reciprocal of the highest dilution
of serum exhibiting 50% protection of infected cells.
Fig. 2. (A) Levels of H-specific antibody in mice after intraperitoneal
immunization with transgenic peanut leaf extract. The geometric mean
titer is defined as the log of the reciprocal of the highest dilution of the
serum, which gave optical density twice as that given by serum from
mice immunized with marker transformed peanut leaf extract. (B) Anti-H
antibodies detected by Western blot in the pooled serum from mouse
immunized intraperitoneally with transgenic peanut leaf extract. Unin-
fected Vero cell lysate (lane 1), RPV-infected Vero cell lysate (lane 2),
and PPRV-infected Vero cell lysate (lane 3) were used as source of
antigens.
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Lymphocytes underwent proliferation in a dose-dependent
manner suggesting the presence of primed cells (Fig. 5).
Additionally, these lymphocytes did not proliferate inFig. 3. Hemagglutination inhibition assay. Hemagglutination inhibition
titers of pooled serum from five mice after immunization (i.p.) with
transgenic peanut leaf extract (group 1:x) and with vector-transformed
peanut leaf extract (group 2: n) measured at every week after immunization
for 9 weeks. Hemagglutination inhibition titer is defined as the reciprocal of
the dilution, which showed 50% hemagglutination inhibition.response to uninfected cell lysate. Further, the specificity
of proliferation was tested by the ability of lymphocytes
to proliferate in response to recombinant viral antigens
such as H, N (nucleocapsid protein), and M (matrix
protein). The lymphocytes from orally primed animals
proliferated in response to recombinant H and not to N or
M. The lymphocytes from mice that received nontrans-Fig. 4. (A) Anti-H IgG responses in serum after oral immunization. The
open bar and filled bar represent the mean optical density for the animals
that received the transgenic peanut expressing H and the nontransformed
peanut leaves, respectively. (B) Anti-H IgA responses in serum after oral
immunization. The filled bar represent the mean OD405 obtained from
mice fed with vector-transformed peanut leaves and open bars represent
the mean OD405 obtained from mice fed with transgenic peanut leaves
expressing H.
Fig. 5. Lymphoproliferative responses at 13 weeks post-oral immunization.
Square (n) and diamonds (x) represent the antigens from RPV-infected and
uninfected cells, respectively. Circle (.) and triangle (E) represent the
nucleocapsid and the matrix proteins of RPV. Filled icons represent the
lymphocytes from animal that received transgenic peanut expressing H, and
empty icons represent the lymphocytes from animal that received
nontransformed peanut leaves.
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antigen.Discussion
The hemagglutinin protein present on the envelope of
RPV is highly immunogenic and protective as shown earlier
(Ohishi et al., 2000; Romero et al., 1994; Yilma et al.,
1988). Recombinant capripox virus (Romero et al., 1994) or
vaccinia virus (Yamanouchi et al., 1993; Yilma et al., 1988)
expressing H alone have been shown to confer protection
against rinderpest. Although these subunit vaccines are able
to overcome the major disadvantage of tissue culture-adap-
ted vaccine (Plowright, 1962), which is heat stability, they
are prohibitively expensive for large-scale production and
need expertise. Further, the debate on the safety aspects of
use of vaccinia virus-based vaccine is still not resolved. Use
of plants as source of vaccine proposed by Arntzen (Mason
et al., 1992) has dual advantage. First, they provide an
inexpensive way to produce the protective antigen in bulk,
and second, if expressed in edible parts, the plant can be
eaten raw offering a novel way of antigen administration.
Earlier, we had generated transgenic tobacco plants express-
ing H protein as a model system to demonstrate that
tobacco-derived H is antigenically authentic and immuno-
genic in a mouse model (Khandelwal et al., 2003a). High
levels of alkaloids present in tobacco make it unsuitable for
animal feeding experiments. We have selected peanut as the
plant of choice to express hemagglutinin protein because the
plants are used as cattle feed after harvest in developing
countries, and in the present communication, we have
evaluated the antigenicity and oral immunogenicity of
peanut derived-H.H protein expressed in peanut is antigenically authentic as
it was recognized by specific antibodies including convales-
cent serum from animals recovered from either RPV or
PPRV infection. The immune responses elicited by the
peanut-derived H are comparable to what is obtained by
recombinant viral vectors. It has been shown for measles
virus that the mode of antigen presentation determines the
extent of immune response (Wild et al., 1992) and our results
are in accordance with this. A small amount of H (10 Ag)
present in the total soluble protein results in high titers of
specific antibody response when given intraperitoneally
(Fig. 2) suggesting that the presence of other plant proteins
are helping the presentation of peanut-derived H to the
components of the immune system. The specificity of the
induced antibody response is evident by the fact that mice
immunized with the extract from vector-transformed plant
do not show any detectable immune response at the given
dose. Similarly, mice fed orally with transgenic peanut
leaves elicited significant immune responses (Fig. 4). Earli-
er, it has been reported that recombinant H protein of RPV
elicits both humoral and cell-mediated responses in cattle
(Sinnathamby et al., 2001). In the present work, oral feeding
of mice with transgenic peanut leaves expressing H without
any mucosal adjuvant not only induces humoral responses as
determined by serum IgG and IgA specific to H but also
primes T cells, the major component of cell-mediated
immune response. This suggests that some plant component,
mainly lectins, might be responsible for induction of sys-
temic and mucosal immune response by facilitating the entry
of peanut-derived antigen across the mucosal barrier. Addi-
tionally, it has been previously suggested that the expression
of antigens in plants will provide a ‘‘bio-encapsulation’’ to
the antigens thus resulting in elicitation of significant mu-
cosal immune response to antigen that is otherwise difficult
to achieve (Kong et al., 2001). Because the use of adjuvant
will stimulate the mucosal immune system nonspecifically
resulting in induction of immune response to the normal diet
of an individual, the results obtained without any oral
adjuvant assume greater significance. Another important
feature of the results from the present work is that the
formulation used for oral immunization does not cause oral
tolerance, instead elicited good immune responses.
The reports available on developing edible vaccine for
human and animal diseases deal with expression of the
candidate antigen in the target plant species and immune
responses in murine models. LT-B of E. coli (Tacket et al.,
1998) and capsid protein of Norwalk virus (Tacket et al.,
2000) when expressed in potato elicit high levels of immune
response in humans. Eating raw potato causes stomach
discomfort or nausea due to presence of alkaloids in potato
as experienced by few of the volunteers receiving transgenic
potatoes expressing LT-B (Tacket et al., 1998). Among the
viral disease of livestock, efforts have been made in
developing edible vaccine for foot and mouth disease
(Carrillo et al., 1998, 2001; Dus Santos et al., 2002;
Wigdorovitz et al., 1999a, 1999b) and transmissible gastro-
A. Khandelwal et al. / Virologenteritis (Gomez et al., 1998, 2000; Tuboly et al., 2000).
However, in case of animal diseases, there are no reports
describing induction of mucosal and systemic immune
responses upon oral delivery through food in the host
animal, although these responses have been obtained in
mouse system. VP1 protein of foot and mouth disease virus
when expressed in arabidopsis and potato (Carrillo et al.,
1998, 2001) and in tobacco (Wigdorovitz et al., 1999b) is
shown to induce protective immune response in mice upon
intraperitoneal immunization. Wigdorovitz et al. (1999a)
have also shown that oral or parenteral immunization of
mice with alfalfa expressing VP1 induces protective im-
mune response. The expression levels were found to be in
the range of 0.005–0.01% of the total soluble protein as
estimated by ELISA and even the promoter modification
did not result in significant increase of the VP1 expression
in transgenic lines (Carrillo et al., 2001). We have selected
peanut as the target plant, which is also a fodder crop, and
the peanut-expressed hemagglutinin protein induces high
levels of specific antibody response upon intraperitoneal
immunization with extract from transgenic peanut leaves or
oral immunization with peanut leaves. Protection provided
at the entry site of the infectious organism would not only
protect the animal from the disease but also prevent the
infection altogether. Oral immunogenicity of peanut-
expressed H protein in the target animal cattle has been
recently shown (Khandelwal et al., 2003c); however, it was
necessary to find if the peanut-derived protein is able to
elicit secretory IgA response after oral feeding. In conclu-
sion, a safe, easy to administer and cost effective, both in
terms of production and storage, candidate vaccine has been
produced in transgenic peanut plants and the plant-
expressed H is immunogenic when given orally without
adjuvant in a model animal. This may provide a novel way
of protecting livestock against rinderpest disease.Materials and methods
Animals
BALB/c (H-2d) female mice 60–90 days old were
procured and maintained at Central Animal Facility, Indian
Institute of Science, Bangalore, India.
Cells and virus
Vero cells were obtained from National center for cell
Science, Pune, India, and were maintained in MEM supple-
mented with 5% fetal calf serum (Gibco-BRL, USA). A
tissue culture-adapted vaccine strain of RPV (RBOK) (Plo-
wright and Ferris, 1957) was obtained from the Institute of
Animal Health and Veterinary Biologicals, Bangalore, India,
and vaccine strain of peste des petits ruminants virus
(PPRV) Nig 75/1 was provided by Dr. A. Diallo, CIRAD-
EMVT, France.Recombinant proteins
Recombinant hemagglutinin (H) protein expressed in
insect cells secreted into the medium was used (Naik and
Shaila, 1997). Recombinant nucleocapsid of RPV expressed
in E. coli was purified on Ni affinity column as described
earlier (Mitra-Kaushik et al., 2001). The full-length M gene
of RPV (RBOK) was cloned into pBluesript KS+ vector
(kindly provided by Dr. M. Baron, Institute for Animal
Health, Pirbright, UK), was subcloned into pRSET expres-
sion vector, and expressed in E. coli BL21 (DE3) (Shaji and
Shaila, unpublished).
Antibodies
H-specific antibodies made in cattle in response to
immunization with a baculo-recombinant virus expressing
H protein are described earlier (Sinnathamby et al., 2001).
Convalescent sera from cattle recovered from RPV infection
or sheep recovered from PPRV infection were collected
during field outbreaks. Generation of mouse monoclonal
antibody to baculo-recombinant secretory H is described in
Renukaradhya et al. (2002). Polyclonal monospecific anti-
bodies to RPV H purified from infected cell extracts were
generated in rabbits (Devirddy et al., 1998).
Transgenic peanut plants
The hemagglutinin gene (H) of attenuated strain (RBOK)
of rinderpest virus was subcloned into binary vector pBI 121.
In the recombinant binary vector pBI H, the H gene is under
the control of constitutively expressed CaMV 35S promoter.
pBI H was mobilized into Agrobacterium tumefaciens (EHA
105). Transgenic peanut plants obtained using pBI121
served as the control and termed as vector-transformed
peanut plants. Transgenic peanut plants expressing hemag-
glutinin protein were generated via Agrobacterium-mediated
transformation of shoot apices (Khandelwal et al., 2003b).
ELISA
Total protein from leaves of transformed and nontrans-
formed peanut plants was isolated using the method of
McGarvey et al. (1995). Twofold serial dilution of plant
extracts was performed in phosphate buffer, pH 7.4 (PBS),
and coated onto ELISA plates at 4 jC overnight. All further
incubations were at 37 jC for 1 h and the plate was washed
thrice with PBS containing 0.15 Tween 20 (PBST). Block-
ing was done in 0.2% fish gelatin in PBST (v/v). Appro-
priate antibody dilutions were made for all primary
antibodies followed by peroxidase-conjugated anti-cow,
anti-sheep (purchased from Dacopatts, Denmark), or anti-
rabbit (purchased from Boehinger and Mannheim) anti-
bodies as secondary antibodies. The HRP antibody was
developed with o-phenylenediamine (OPD) for 10–15 min
and read at 490 nm.
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Two groups, each containing 5 BALB/c mice, were
immunized intraperitoneally with leaf extracts from trans-
formed peanut plants expressing highest level of H and
vector-transformed peanut plants (10 Ag of H per mouse) in
complete Freund’s adjuvant for the first injection followed
by two boosters with half of the protein amount on 7 and 14
days in incomplete Freund’s adjuvant. Mice were bled retro-
orbitally every week until 10 weeks post-immunization and
serum was collected and tested for the presence of specific
antibodies to H by ELISA using recombinant H as the
antigen. Antibody titers are expressed as the log of recip-
rocal of the highest serum dilution that gives OD readings
twice the mean OD of serum from five mice immunized
with vector-transformed peanut plant extract.
For oral immunization, two groups of mice each con-
taining four animals were used. Animals were starved
overnight before feeding in the morning. They were fed
with 1 g of peanut leaves (either transgenic leaves, group 1
or nontransformed peanut leaves, group 2) corresponding to
10 Ag of H per feeding once a week for five consecutive
weeks.
Hemagglutination inhibition assay
Hemagglutination inhibition test to detect specific anti-
serum was done employing PPRV, closely related to RPV,
which has been shown to possess hemagglutination activity
(Ramachandran et al., 1995) using the method previously
described by Norrby (1962).
Virus neutralization test
Serum samples collected at various time points were
tested for the presence of neutralizing antibodies (both
homologous and cross-neutralizing) in triplicates using flat-
bottomed 96-well plates as described by Barrett et al. (1989).
Vaccine strain of RPV (RBOK strain) and vaccine strain of
PPRV Nig 75/1 were grown on Vero cells and titrated
employing TCID50 method (Reed and Muench, 1938).
Pooled serum samples (for each bleed, serum was pooled
from all the five mice of the group) were heat inactivated at
56 jC for 30 min and then serially diluted twofold with
culture medium, starting from an initial dilution of 1:20.
Following incubation with 100 TCID50 of virus at 37 jC for 1
h, 2  104 cells were added to each well. The wells without
the sera or virus served as control. The plates were monitored
for 5–7 days for cytopathic effects (CPE) for RPV and 3–5
days for PPRV. Virus neutralization titer was defined as the
highest dilution of the sera, which inhibited CPE by 50%.
In vitro lymphoproliferation
Spleen was collected from orally immunized animals at
13 weeks. Lymphoid cell suspension was subjected to ficoll-
A. Khandelwal et al. / V290Hypaque (Pharmacia) density centrifugation at 3000 rpm for
30 min. The buffy coat was collected and diluted in excess
PBS. The cells were recovered by centrifugation, washed,
and resuspended in RPMI 1640 supplemented with 10%
FBS (Gibco BRL). The lymphocytes were proliferated in
triplicates at a density of 2  104 cells per well in presence
of varying amounts of RPV-infected cell lysate or uninfect-
ed cell lysate or recombinant proteins in a final volume of
200 Al per well for 5 days. The cells were pulsed with 1 ACi
[3H]-thymidine (specific activity 6500 mCi/mmol; Amer-
sham) for 16 h and harvested on glass fiber filters. The
incorporated radioactivity was measured in a Rackbeta
scintillation spectrometer.Acknowledgments
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